PQ 827
827. Deputy Seán Canney asked the Minister for Health if she will expedite the process of approval for givinostat, used in the treatment of Duchenne Muscular Dystrophy, as further delays could affect the ability of patients to retain muscular strength and the current process for drug approval in Ireland can take on average 617 days, during which time muscular dystrophy patients will have lost significant muscle strength; and if she will make a statement on the matter. [32237/25]
Introduced
17 June 2025
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
17 June 2025
Summary
827. Deputy Seán Canney asked the Minister for Health if she will expedite the process of approval for givinostat, used in the treatment of Duchenne Muscular Dystrophy, as further delays could affect the ability of patients to retain muscular strength and the current process for drug approval in Ireland can take on average 617 days, during which time muscular dystrophy patients will have lost significant muscle strength; and if she will make a statement on the matter. [32237/25]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 17 June 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-06-17/827/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-06-17/pq_827